Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248816 · ClinicalTrials.gov registry record · NA
Hepatocellular Carcinoma Surveillance in Cirrhotics
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 615
- Enrollment target
NCT04248816: Completed NA study, sponsored by University of Pennsylvania.
NCT04248816 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 615 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248816, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 615 participants
- Enrollment target
Study Summary
This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular carcinoma (HCC).
Primary Outcome
The percentage of subjects who have a surveillance abdominal ultrasound.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Opt-out
- BEHAVIORAL Opt-out + Incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2022-02-14 |
| Phase | NA |
What the finished NCT04248816 record still lists
NCT04248816 is an interventional study that assigns participants to a tested intervention. The registered 615 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT04248816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04248816 about?
NCT04248816 is a clinical study titled "Hepatocellular Carcinoma Surveillance in Cirrhotics". This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular...
What is the current status of trial NCT04248816?
This trial is currently completed. It is a NA study. The enrollment target is 615 participants. The study started on 2020-11-19. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT04248816?
The interventions under investigation include: Usual care (BEHAVIORAL), Opt-out (BEHAVIORAL), Opt-out + Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT04248816?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04248816's enrollment target sits among peer trials
615 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593652 · 615 participants · NA
Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
- NCT04813185 · 616 participants · NA
Preventing Retaliatory Gun Violence in Violently Injured Adults
- NCT06105957 · 616 participants · NA
Optimal Digital Weight Loss Treatment for Rural Individuals
- NCT06162221 · 616 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI